Brain tumor at 82: age becomes the deciding factor

Brain tumor at 82: age becomes the deciding factor

An emergency CT scan detects a brain mass in an 82-year-old patient. Two months earlier, another CT scan showed nothing. The neurologist already speaks of a "very aggressive" tumor given its growth rate. The MRI confirms it is malignant, but its type is unknown. And on the horizon an uncomfortable question appears: is the case being assessed, or is it being shelved because of his date of birth?

Healthcare becomes the first battleground. Ten days admitted to hospital without the MRI. Weekends, public holidays and a growing suspicion: depending on his age, the case may be written off as hopeless. The referral hospital, San Juan de Alicante, has accumulated complaints over care that "has left a lot to be desired". The Valencian Community, it is worth recalling, ranks last among Spain's autonomous regions.

Diagnostic delay as a risk factor

The case illustrates a recurring pattern: delays in testing are not an administrative problem, they are a clinical one. A tumor that grows in weeks does not wait for appointment backlogs to clear. The MRI arrives, but late. And with it, the diagnosis nobody wanted: malignant, untyped. The neurologist announces he will speak with his team to assess the next steps. The possibility that the case will not be assessed because of his age slips into the conversation.

Some maintain that current protocols do not rule anyone out on the grounds of age. If it can be done, it is done. Cases are written off as hopeless when there is nothing left to do, when there are metastases or the tumor is too large or in a bad location. In those circumstances, patients have usually already lost a good deal of rational or physiological capacity. That does not seem to be the case here. Others point out that age is usually not a problem for entering the operating room, unless there are serious chronic illnesses that increase the risk. If he is otherwise healthy, they will not put up much of a fight.

But the doubt persists. Because the system does not always explain its criteria, and because the feeling of abandonment is hard to refute when the days pile up without answers.

The prognosis nobody wants to name

Glioblastoma comes up in the conversation as the most likely diagnosis. An aggressive, fast-growing, branching tumor, difficult to operate on and that almost always grows back. The anecdotes pile up: a cousin by marriage who died after being operated on twice, lasting five years from detection. A friend's elderly mother, who had three tumors detected in one week and lost her mind within a fortnight. A woman who sold bicycles. Cases that are not statistics, but that paint a picture.

The medical literature is not optimistic. Glioblastoma does not respond well to chemo or radiotherapy. Removing it entirely surgically is usually impossible because remnants always remain that reproduce quickly if the tumor is aggressive. And it leaves deficits. Age is not the only factor: the prognosis is very poor with or without treatment. Most likely the oncologists will want at least a biopsy to give the tumor a proper name and see if anything can be done.

Some point out that protocols today do not rule anyone out because of age. And others reply that that is the theory. In practice, the decision depends on factors that are not always explained.

Public healthcare and its timelines

The case exposes a reality many acknowledge: public healthcare responds when the patient is dying or arrives at the emergency room with their guts hanging out. For everything else, the timelines stretch. Delays in diagnostic testing become an added risk factor. A lot of time passes between the onset of symptoms and the tests being done. And that time is crucial.

The recurring alternative is paying. An MRI can be done and interpreted for you for as little as 200 euros. Privately, within a week you can have every test you need. In the public system, it can take nearly a year. The difference is not just estimulante ilegal: it is access. Those who can pay, estimulante ilegal things up. Those who cannot, wait.

Some maintain that healthcare is, de facto, already privatized. That the public system only responds if you are dying. And that the only way to get rid of six-to-eight-month waits for a test is to pay for it out of your own pocket and take it to the specialist. Then, sometimes, they hurry.

What you can do when the system does not respond

The search for alternatives becomes a race against the clock. Appointments with private doctors. Second opinions. Alternative protocols circulating on the internet that promise what official medicine does not offer. Ivermectin, fenbendazole, lion's mane, MCT oil, methylene blue. Supplements. Alkaline diets. Anything you can imagine.

The scientific evidence does not support these treatments for brain tumors. But desperation knows nothing of systematic reviews. And when the public system leaves you waiting ten days for an MRI, any option seems better than inaction.

The problem is that most of these protocols have not even a clinical trial behind them. They are testimonials. Isolated cases. Stories of a cousin who was cured. And amid it all, the question nobody answers: what can you do when the system does not respond?

---

The case remains open. The diagnosis is confirmed: malignant tumor, untyped. The neurologist will speak with his team. The possibility that the case will not be assessed because of his age is still on the table. And the feeling that the system looks at the date of birth before the medical record does not go away. Meanwhile, the family waits. And searches. And despairs. Because when public healthcare fails, the only safety net is money. And not everyone has it.